Intuitive Ventures
Intuitive Ventures is the corporate venture capital arm of Intuitive Surgical (NASDAQ: ISRG), investing $5-10M+ in early-stage healthcare startups across surgical robotics, medical devices, cell therapy, and digital health, with $250M+ AUM and 15+ portfolio companies.
- Company typePrivate
- Founded2020
- HeadquartersSunnyvale, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Intuitive Ventures does
Intuitive Ventures is the corporate venture capital arm of Intuitive Surgical Operations, Inc. (NASDAQ: ISRG), established in 2020 and headquartered in Sunnyvale, California. The fund focuses on early-stage healthcare startups developing next-horizon solutions across surgical robotics, medical devices, cell therapy, cardiovascular interventions, neuromodulation, AI-driven diagnostics, and digital health. With more than $250 million in assets under management and an active portfolio of 15+ companies, Intuitive Ventures provides equity capital — typically $5-10 million or more per first investment — alongside practical guidance drawn from Intuitive Surgical's three decades of healthcare, regulatory, and commercialization expertise.
The fund's product offering is differentiated less by novel technology than by embedded strategic support: portfolio companies gain access to Intuitive Surgical's clinical, technical, regulatory, and commercial network, and benefit from a partnership model that emphasizes rigor, decisiveness, and sustained engagement. Notable portfolio investments include Capstan Medical (robotic heart valve technology), Cellares (cell therapy manufacturing automation), VahatiCor (coronary microvascular dysfunction therapy), XII Medical (neuromodulation for sleep apnea), Amber Therapeutics (neuromodulation for urinary incontinence), Apreo Health (endobronchial emphysema treatment), Neocis (dental surgical robotics), Optellum (AI lung cancer diagnosis), Flywheel (imaging data platform), and Medcrypt (medical device cybersecurity), with named exits including KelaHealth and OrganOx.
Intuitive Ventures operates with a lean team of 1-10 employees led by Managing Partner and President Murielle Thinard McLane, with Executive Chairman Gary Guthart, PhD (also CEO of Intuitive Surgical), four venture advisors with clinical and operating backgrounds, and dedicated medical and finance professionals. As a wholly-owned subsidiary of a publicly traded strategic parent, the fund enjoys patient capital and access to a global commercialization infrastructure that most independent healthcare VCs cannot replicate, while operating with the agility of an independent venture fund.
Intuitive Ventures firmographics
Firmographics- Name
- Intuitive Ventures
- Legal name
- Intuitive Surgical Operations, Inc.
- Website
- https://ventures.intuitive.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Intuitive Ventures is the corporate venture capital arm of Intuitive Surgical (NASDAQ: ISRG), investing $5-10M+ in early-stage healthcare startups across surgical robotics, medical devices, cell therapy, and digital health, with $250M+ AUM and 15+ portfolio companies.
- Ownership category
- akta.pro rank
Intuitive Ventures industry classification
Industry- Product category
- Healthcare Venture Capital
- NAICS
- Funds, Trusts, and Other Financial Vehicles (525), Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394), Other Financial Vehicles (525990)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Corporate Accelerators & Startup Programs (FSANAHAD)
Keywords
Where Intuitive Ventures is headquartered
LocationHeadquarters
- HQ city
- Sunnyvale
- HQ country
- United States
- HQ region
- North America
Markets served
Intuitive Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Distribution channels1 record
Marketing channels2 records
Intuitive Ventures product offering
Product offeringCore offering
Intuitive Ventures is the corporate venture capital fund of Intuitive Surgical Operations, Inc., deploying $5–10M+ average first investments into early-stage healthcare startups developing next-horizon medical technologies including surgical robotics, cell therapy, cardiovascular interventions, neuromodulation, and AI-driven diagnostics. Beyond capital, portfolio companies receive practical guidance drawn from Intuitive Surgical's deep technical, clinical, regulatory, and commercial experience spanning three decades.
Product overview
Intuitive Ventures is a single unified corporate venture capital fund, not a product company. It operates as the venture arm of Intuitive Surgical, focusing on early-stage healthcare investments. The fund deploys capital across 15+ portfolio companies spanning medical devices, diagnostics, digital health, and healthcare technology. Beyond funding, the fund provides practical guidance, industry expertise, and network access to portfolio companies. The portfolio includes select investments in XII Medical (neuromodulation for sleep apnea), Amber Therapeutics (neuromodulation for urinary incontinence), Apreo Health (endobronchial treatment), Capstan Medical (robotic heart valve technology), Cellares (cell therapy manufacturing automation), Dragon Vascular (neurovascular solutions), Endogenex (GI/metabolic therapies), Flywheel (imaging data management), Medcrypt (medical device cybersecurity), Neocis (dental surgical robotics), Optellum (AI lung cancer diagnosis), Surge (immunotherapy delivery), and VahatiCor (cardiac microvascular dysfunction treatment), along with exited investments in KelaHealth and OrganOx.
Differentiator
Problem solved
Functional benefit
Products and services
- Intuitive Ventures Fund Corporate venture capital fund providing $5–10M+ average first investments to early-stage healthcare startups, with $250M+ in assets under management. The fund invests across medical devices, surgical robotics, diagnostics, cell therapy, digital health, and related healthcare technology, and provides portfolio companies with practical guidance drawn from Intuitive Surgical's 30+ years of healthcare innovation experience.
Companies that use Intuitive Ventures
Customer profileSegments1 record
Ideal customer profiles1 record
Intuitive Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Intuitive Ventures partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
Intuitive Ventures competitors and assessment
Company assessmentDirect peers
- Medtronic Ventures: Corporate venture capital arm of Medtronic, a global medical device leader. Directly comparable as a medical-device-focused CVC deploying strategic capital into early-stage companies, often providing clinical and regulatory expertise similar to Intuitive Ventures.
- Johnson & Johnson Innovation (JJDC): Corporate venture capital arm of Johnson & Johnson investing across medical devices, pharmaceuticals, and digital health. Comparable as a healthcare-focused CVC with multi-stage deployment and deep strategic resources available to portfolio companies.
- Roche Venture Fund: Corporate venture capital arm of Roche investing in diagnostics, medical devices, and digital health. Comparable as a healthcare-focused CVC leveraging its parent's deep clinical and commercial expertise to support early-stage companies.
- Optum Ventures: Corporate venture capital arm of Optum/UnitedHealth Group investing in healthcare technology, digital health, and AI-driven care. Comparable as a healthcare-focused CVC providing strategic capital with access to the parent's distribution and data assets.
- Novo Holdings (Novo Ventures): Investment arm of the Novo Nordisk Foundation with significant healthcare and life sciences venture activity. Comparable as a long-horizon, healthcare-specialist investor with deep domain expertise and substantial AUM.
- Bain Capital Life Sciences: Healthcare and life-sciences-focused venture and growth fund within Bain Capital. Comparable as a multi-stage healthcare investor with multi-hundred-million-dollar fund sizes and concentrated exposure to medical devices and biotech.
- OrbiMed: Healthcare-dedicated investment firm across venture, growth, and credit strategies. Comparable as a deep healthcare-specialist investor with extensive portfolio breadth across devices, diagnostics, and digital health.
- Andreessen Horowitz Bio: Healthcare and bio fund within Andreessen Horowitz, investing across digital health, biotech, and medical devices. Comparable as a multi-stage healthcare investor pairing capital with operator network value-add.
Broad incumbents
- Khosla Ventures: Broad technology and healthcare venture firm. Comparable as a healthcare-active generalist VC with deep portfolio exposure to medical devices, diagnostics, and digital health, though not a dedicated CVC.
Emerging players
- 8VC: Venture firm with meaningful healthcare and bio portfolio activity. Comparable as an active participant in healthcare venture rounds with a track record of building healthtech and medical device companies, though smaller and broader in mandate than Intuitive Ventures.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks4 records
Key highlights5 records
Customer concentration
Intuitive Ventures social profiles
Digital presenceIntuitive Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Intuitive Ventures leadership team
Management profileNumber of profiles
Profiles13 records
Intuitive Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Intuitive Ventures M&A and investment
M&A and investmentM&A
Investments21 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Intuitive Ventures
What does Intuitive Ventures do?
Intuitive Ventures is the corporate venture capital fund of Intuitive Surgical Operations, Inc., deploying $5–10M+ average first investments into early-stage healthcare startups developing next-horizon medical technologies including surgical robotics, cell therapy, cardiovascular interventions, neuromodulation, and AI-driven diagnostics. Beyond capital, portfolio companies receive practical guidance drawn from Intuitive Surgical's deep technical, clinical, regulatory, and commercial experience spanning three decades.
Is Intuitive Ventures a public or private company?
Intuitive Ventures is a private company. It is classified as corporate owned and is currently operating.
When was Intuitive Ventures founded?
Intuitive Ventures was founded in 2020. It employs 1 to 10 people.
Where is Intuitive Ventures based?
Intuitive Ventures is headquartered in Sunnyvale, United States, in the North America region.
Who are Intuitive Ventures's main competitors?
Direct peers on record are Medtronic Ventures, Johnson & Johnson Innovation (JJDC), Roche Venture Fund, Optum Ventures, Novo Holdings (Novo Ventures), Bain Capital Life Sciences, OrbiMed and Andreessen Horowitz Bio. Khosla Ventures is listed as a broad incumbent. 8VC is listed as an emerging player.
Does Intuitive Ventures have an API?
No public API is recorded for Intuitive Ventures.
What industry is Intuitive Ventures in?
Intuitive Ventures's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAHAD, Corporate Accelerators & Startup Programs. Its NAICS code is 525 and its SIC code is 6282.